Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease.

Dorota A. Kedziorek, Dara L. Kraitchman

Research output: Contribution to journalArticle

Abstract

In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

Original languageEnglish (US)
Pages (from-to)171-183
Number of pages13
JournalMethods in molecular biology (Clifton, N.J.)
Volume660
StatePublished - 2010

Fingerprint

Cardiovascular Diseases
Stem Cells
Magnetic Resonance Imaging
Clinical Trials
Diagnostic Imaging
Cell- and Tissue-Based Therapy
Nanoparticles
Contrast Media
ferric oxide
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{cb2f007cd58145f8b8ef0b415695480d,
title = "Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease.",
abstract = "In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.",
author = "Kedziorek, {Dorota A.} and Kraitchman, {Dara L.}",
year = "2010",
language = "English (US)",
volume = "660",
pages = "171--183",
journal = "Methods in Molecular Biology",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease.

AU - Kedziorek, Dorota A.

AU - Kraitchman, Dara L.

PY - 2010

Y1 - 2010

N2 - In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

AB - In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

UR - http://www.scopus.com/inward/record.url?scp=83455184459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455184459&partnerID=8YFLogxK

M3 - Article

C2 - 20680819

VL - 660

SP - 171

EP - 183

JO - Methods in Molecular Biology

JF - Methods in Molecular Biology

SN - 1064-3745

ER -